Scott Hadland MD

Scott Hadland, MD, MPH

Associate in Medicine

Instructor in Pediatrics, Harvard Medical School

    Contact: 617-355-7181
  • Fax: 617-730-0184

Medical Services

Specialties

  • Adolescent Medicine
  • Pediatrics
  • Addiction Medicine

Departments

  • Adolescent Medicine
  • Medicine

Languages

  • English
  • French
  • Spanish

Programs

  • Adolescent Substance Abuse Program
  • Martha Eliot Health Center
  • Adolescent/Young Adult Medical Practice
To schedule an appointment: Call 617-355-7181 or Request an Appointment
Scott Hadland MD

 

I believe that we all need to give patients the time they deserve – to be present and involved in every patient interaction.  I never want my patients to feel rushed, or feel as though some part of their care was glossed over.

I entered medicine in order to provide outstanding care to patients struggling with problems that sometimes go unaddressed by the medical system.  For me, this means making sure I confront issues that might be considered too complicated by some, like questions of mental health or addiction.

Experience and Education

Education

Medical School

Washington University in St. Louis, 2009

St. Louis, MO

Internship

Boston Children's Hospital/Boston Medical Center, 2010

Boston, MA

Residency

Boston Children's Hospital/Boston Medical Center, 2012

Boston, MA

Chief Residency

Boston Children's Hospital/Boston Medical Center, 2013

Boston, MA

Fellowship, Adolescent Medicine

Boston Children's Hospital, 2015

Boston, MA

Certifications

Professional History

My goal is to provide exceptional care to adolescents and young adults. Although I am a primary care physician by training, I am also a specialist in drug and alcohol addiction, and routinely provide care to youth who are lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ). Since 2007, I have conducted research in the field of substance use to understand the underpinnings of addiction and determine the most effective ways to treat it. Through my clinical work, research, and education, I hope to improve the well-being of vulnerable youth and invest in the health of generations to come.

Publications

Publications powered by Harvard Catalyst Profiles
  1. Joyce NR, Schuler MS, Hadland SE, Hatfield LA. Variation in the 12-Month Treatment Trajectories of Children and Adolescents After a Diagnosis of Depression. JAMA Pediatr. 2017 Nov 20.
  2. Joyce NR, Huskamp HA, Hadland SE, Donohue JM, Greenfield SF, Stuart EA, Barry CL. The Alternative Quality Contract: Impact on Service Use and Spending for Children With ADHD. Psychiatr Serv. 2017 Dec 01; 68(12):1210-1212.
  3. Huskamp HA, Samples H, Hadland SE, McGinty EE, Gibson TB, Goldman HH, Busch SH, Stuart EA, Barry CL. Mental Health Spending and Intensity of Service Use Among Individuals With Diagnoses of Eating Disorders Following Federal Parity. Psychiatr Serv. 2017 Nov 15; appips201600516.
  4. Bagley SM, Hadland SE, Carney BL, Saitz R. Addressing Stigma in Medication Treatment of Adolescents With Opioid Use Disorder. J Addict Med. 2017 Nov/Dec; 11(6):415-416.
  5. Soipe AI, Taylor LE, Abioye AI, Green TC, Hadland SE, Marshall BDL. Prevalence of Hepatitis C Screening, Testing, and Care Experience Among Young Adults Who Use Prescription Opioids Nonmedically. J Adolesc Health. 2017 Oct 20.
  6. Hadland SE, Krieger MS, Marshall BDL. Industry Payments to Physicians for Opioid Products, 2013-2015. Am J Public Health. 2017 Sep; 107(9):1493-1495.
  7. Naimi TS, Xuan Z, Coleman SM, Lira MC, Hadland SE, Cooper SE, Heeren TC, Swahn MH. Alcohol Policies and Alcohol-Involved Homicide Victimization in the United States. J Stud Alcohol Drugs. 2017 Sep; 78(5):781-788.
  8. Hadland SE, Wood E, Nosova E, Kerr T, DeBeck K. Cessation of Injecting and Preceding Drug Use Patterns Among a Prospective Cohort of Street-Involved Youth. J Adolesc Health. 2017 Nov; 61(5):612-618.
  9. Hadland SE, Wharam JF, Schuster MA, Zhang F, Samet JH, Larochelle MR. Trends in Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder Among Adolescents and Young Adults, 2001-2014. JAMA Pediatr. 2017 Aug 01; 171(8):747-755.
  10. Liebling EJ, Green TC, Hadland SE, Marshall BDL. Injection drug use and overdose among young adults who use prescription opioids non-medically. Addict Behav. 2018 Jan; 76:20-26.
  11. Show all
  12. Evans TI, Liebling EJ, Green TC, Hadland SE, Clark MA, Marshall BDL. Associations Between Physical Pain, Pain Management, and Frequency of Nonmedical Prescription Opioid Use Among Young Adults: A Sex-specific Analysis. J Addict Med. 2017 Jul/Aug; 11(4):266-272.
  13. Welsh JW, Knight JR, Hadland SE. Adolescent Frequent Heavy Drinking From 1991-2015. Pediatrics. 2017 06; 139(6).
  14. Bouvier BA, Elston B, Hadland SE, Green TC, Marshall BD. Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study. Harm Reduct J. 2017 Feb 20; 14(1):13.
  15. Hadland SE, Xuan Z, Sarda V, Blanchette J, Swahn MH, Heeren TC, Voas RB, Naimi TS. Alcohol Policies and Alcohol-Related Motor Vehicle Crash Fatalities Among Young People in the US. Pediatrics. 2017 Mar; 139(3).
  16. Hadland SE, Copelas SH, Harris SK. Trajectories of Substance Use Frequency among Adolescents Seen in Primary Care: Implications for Screening. J Pediatr. 2017 May; 184:178-185.
  17. Macmadu A, Carroll JJ, Hadland SE, Green TC, Marshall BD. Prevalence and correlates of fentanyl-contaminated heroin exposure among young adults who use prescription opioids non-medically. Addict Behav. 2017 May; 68:35-38.
  18. Harris SK, Aalsma MC, Weitzman ER, Garcia-Huidobro D, Wong C, Hadland SE, Santelli J, Park MJ, Ozer EM. Research on Clinical Preventive Services for Adolescents and Young Adults: Where Are We and Where Do We Need to Go? J Adolesc Health. 2017 Mar; 60(3):249-260.
  19. Hadland SE, Yehia BR, Makadon HJ. Caring for Lesbian, Gay, Bisexual, Transgender, and Questioning Youth in Inclusive and Affirmative Environments. Pediatr Clin North Am. 2016 Dec; 63(6):955-969.
  20. Liebling EJ, Yedinak JL, Green TC, Hadland SE, Clark MA, Marshall BD. Access to substance use treatment among young adults who use prescription opioids non-medically. Subst Abuse Treat Prev Policy. 2016 Nov 29; 11(1):38.
  21. Yedinak JL, Kinnard EN, Hadland SE, Green TC, Clark MA, Marshall BD. Social context and perspectives of non-medical prescription opioid use among young adults in Rhode Island: A qualitative study. Am J Addict. 2016 Dec; 25(8):659-665.
  22. Naimi TS, Xuan Z, Cooper SE, Coleman SM, Hadland SE, Swahn MH, Heeren TC. Alcohol Involvement in Homicide Victimization in the United States. Alcohol Clin Exp Res. 2016 Dec; 40(12):2614-2621.
  23. Hadland SE, Wood E, Levy S. How the paediatric workforce can address the opioid crisis. Lancet. 2016 Sep 24; 388(10051):1260-1.
  24. Evans TI, Hadland SE, Clark MA, Green TC, Marshall BD. Factors associated with knowledge of a Good Samaritan Law among young adults who use prescription opioids non-medically. Harm Reduct J. 2016 Jul 26; 13(1):24.
  25. Hadland SE, Walker LR. Medical Comorbidity and Complications. Child Adolesc Psychiatr Clin N Am. 2016 07; 25(3):533-48.
  26. Hadland SE, Levy S. Objective Testing: Urine and Other Drug Tests. Child Adolesc Psychiatr Clin N Am. 2016 07; 25(3):549-65.
  27. Marshall BD, Green TC, Yedinak JL, Hadland SE. Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities. Int J Drug Policy. 2016 May; 31:25-31.
  28. Hadland SE, Knight JR, Harris SK. The Knowledge Gaps for Medical Marijuana in Pediatric Conditions. J Dev Behav Pediatr. 2015 Nov-Dec; 36(9):767-8.
  29. Hadland SE, Xuan Z, Blanchette JG, Heeren TC, Swahn MH, Naimi TS. Alcohol Policies and Alcoholic Cirrhosis Mortality in the United States. Prev Chronic Dis. 2015 Oct 15; 12:E177.
  30. Hadland SE, Knight JR. Brief Interventions for Alcohol Use: Where, When, and How? Pediatrics. 2015 Oct; 136(4):e1002-4.
  31. Hadland SE, Wood E, Dong H, Marshall BD, Kerr T, Montaner JS, DeBeck K. Suicide Attempts and Childhood Maltreatment Among Street Youth: A Prospective Cohort Study. Pediatrics. 2015 Sep; 136(3):440-9.
  32. Xuan Z, Blanchette JG, Nelson TF, Nguyen TH, Hadland SE, Oussayef NL, Heeren TC, Naimi TS. Youth Drinking in the United States: Relationships With Alcohol Policies and Adult Drinking. Pediatrics. 2015 Jul; 136(1):18-27.
  33. Hadland SE, Knight JR, Harris SK. Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice. J Dev Behav Pediatr. 2015 Feb-Mar; 36(2):115-23.
  34. Ostrom K, Syan R, Barber L, Miller D, Venkatasubramani N, Ravindra A, Jhaveri P, Jhaveri P, Alexander C, Nagan MR, Hauptman M, Grover A, Hadland SE. Index of suspicion. Pediatr Rev. 2014 Sep; 35(9):396-404.
  35. Hadland SE, Harris SK. Youth marijuana use: state of the science for the practicing clinician. Curr Opin Pediatr. 2014 Aug; 26(4):420-7.
  36. Hadland SE, DeBeck K, Kerr T, Feng C, Montaner JS, Wood E. Prescription opioid injection and risk of hepatitis C in relation to traditional drugs of misuse in a prospective cohort of street youth. BMJ Open. 2014 Jul 21; 4(7):e005419.
  37. Hadland SE, DeBeck K, Kerr T, Nguyen P, Simo A, Montaner JS, Wood E. Use of a medically supervised injection facility among street youth. J Adolesc Health. 2014 Nov; 55(5):684-9.
  38. Hadland SE, Long WE. A systematic review of the medical home for children without special health care needs. Matern Child Health J. 2014 May; 18(4):891-8.
  39. Hadland SE, Baer TE. The racial and ethnic gap in substance use treatment: implications for U.S. healthcare reform. J Adolesc Health. 2014 Jun; 54(6):627-8.
  40. Hadland SE, Austin SB, Goodenow CS, Calzo JP. Weight misperception and unhealthy weight control behaviors among sexual minorities in the general adolescent population. J Adolesc Health. 2014 Mar; 54(3):296-303.
  41. Marshall BD, Hadland SE. The immediate and lasting effects of adolescent homelessness on suicidal ideation and behavior. J Adolesc Health. 2012 Nov; 51(5):407-8.
  42. Hadland SE, Werb D, Kerr T, Fu E, Wang H, Montaner JS, Wood E. Childhood sexual abuse and risk for initiating injection drug use: a prospective cohort study. Prev Med. 2012 Nov; 55(5):500-4.
  43. Hadland SE, Marshall BD, Kerr T, Lai C, Montaner JS, Wood E. Ready access to illicit drugs among youth and adult users. Am J Addict. 2012 Sep-Oct; 21(5):488-90.
  44. Hadland SE, Wood E. Commentary on Bruneau et al. (2012): injection of prescription opioid pain relievers and infectious disease risk. Addiction. 2012 Jul; 107(7):1328-9.
  45. Hadland SE, Milloy MJ, Kerr T, Zhang R, Guillemi S, Hogg RS, Montaner JS, Wood E. Young age predicts poor antiretroviral adherence and viral load suppression among injection drug users. AIDS Patient Care STDS. 2012 May; 26(5):274-80.
  46. Hadland SE, Marshall BD, Kerr T, Qi J, Montaner JS, Wood E. Suicide and history of childhood trauma among street youth. J Affect Disord. 2012 Feb; 136(3):377-80.
  47. Hadland SE, Marshall BD, Kerr T, Zhang R, Montaner JS, Wood E. A comparison of drug use and risk behavior profiles among younger and older street youth. Subst Use Misuse. 2011; 46(12):1486-94.
  48. Hadland SE, Marshall BD, Kerr T, Qi J, Montaner JS, Wood E. Depressive symptoms and patterns of drug use among street youth. J Adolesc Health. 2011 Jun; 48(6):585-90.
  49. Hadland SE, Kerr T, Marshall BD, Small W, Lai C, Montaner JS, Wood E. Non-injection drug use patterns and history of injection among street youth. Eur Addict Res. 2010; 16(2):91-8.
  50. Hadland SE, Kerr T, Li K, Montaner JS, Wood E. Access to drug and alcohol treatment among a cohort of street-involved youth. Drug Alcohol Depend. 2009 Apr 01; 101(1-2):1-7.
To schedule an appointment: Call 617-355-7181 or Request an Appointment

Locations

Boston Children’s is so much more than a hospital—it’s a community of researchers, clinicians, administrators, support staff, innovators, teachers, patients and families, all working together to make the impossible possible. ”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital
300 Longwood Avenue, Boston, MA 02115
For Patients: 617-355-6000
For Referring Providers: 844-BCH-PEDS | 844-224-7337

Close